Stocks and Investing Stocks and Investing
Fri, June 28, 2024
Thu, June 27, 2024

Michael Ulz Initiated (VKTX) at Buy and Held Target at $105 on, Jun 27th, 2024


Published on 2024-10-28 12:09:06 - WOPRAI, Michael Ulz
  Print publication without navigation


Michael Ulz of Morgan Stanley, Initiated "Viking Therapeutics, Inc." (VKTX) at Buy and Held Target at $105 on, Jun 27th, 2024.

Michael has made no other calls on VKTX in the last 4 months.



There are 8 other peers that have a rating on VKTX. Out of the 8 peers that are also analyzing VKTX, 0 agree with Michael's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Michael


  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Monday, June 24th, 2024
  • Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $120 on, Monday, June 17th, 2024
  • Steven Seedhouse of "Raymond James" Reiterated at Strong Buy on, Tuesday, June 4th, 2024
  • Naz Rahman of "Maxim Group" Reiterated at Strong Buy and Held Target at $120 on, Tuesday, June 4th, 2024
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $138 on, Wednesday, March 27th, 2024
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $125 on, Tuesday, March 26th, 2024
  • Annabel Samimy of "Stifel" Reiterated at Strong Buy and Held Target at $80 on, Friday, March 15th, 2024
  • Roger Song of "Jefferies" Initiated at Strong Buy and Held Target at $110 on, Thursday, March 7th, 2024
Contributing Sources